Skip to content
The family’s recent financial gains come after experiencing losses between March 22 and April 18, during which the family’s joint stake in Dis-Chem fell by $44.1 million.
Despite the decline, the Saltzmans remain prominent investors on the Johannesburg Stock Exchange (JSE).
The $21.08-million increase in the market value of the Saltzman family’s stake in Dis-Chem solidifies their position as significant investors on the JSE.
By owning these critical assets outright, Dis-Chem aims to enhance its operational efficiency and ensure long-term strategic stability.
The market value of the Saltzman family’s joint stake in Dis-Chem Pharmacies has declined from $487.7 million on Jan. 1 to $465.61 million.
Lynette and Ivan Saltzman own a beneficial 35.12-percent stake in the Gauteng-based Dis-Chem Pharmacies.
The Saltzman family, who own 35.12 percent of Dis-Chem, played a key role in steering its growth into one of South Africa’s largest retail pharmacy chains.
The billionaire Saltzman family, who currently own a 35.1-percent stake in Dis-Chem, have solidified their status as one of the wealthiest families in South Africa.
South African billionaire Saltzman family presently owns a beneficial 35.12-percent stake in Dis-Chem Pharmacies.
Since the Saltzmans founded Dis-Chem Pharmacies more than four decades ago, it has grown into one of the country’s leading retail healthcare groups.
Billionaires.Africa has identified seven companies with direct or indirect interests associated with the Saltzman family.
The Saltzman family owns a beneficial 45.2-percent stake in Dis-Chem Pharmacies.
Over the years, Dis-Chem Pharmacies has grown into one of South Africa’s leading retail healthcare groups.
The payment will be made as part of the healthcare firm’s insurance coverage in South Africa.
The Saltzman family owns a beneficial 45.2-percent share in the healthcare company.